thiazolidines has been researched along with Staphylococcal Infections in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguiar, JS; Albuquerque, JFC; Amorim-Carmo, B; Araújo-Melo, RO; Bôtelho, EX; Costa Júnior, HNP; Damasceno, IZ; Fernandes-Pedrosa, MF; Lima, GMS; Mendes, RFV; Sena, KXFR; Silva, CJA; Silva, TG; Ximenes, RM | 1 |
| Grond, S; Heilbronner, S; Konnerth, MC; Krauss, S; Krismer, B; Peschel, A; Saur, J; Torres Salazar, BO; Wirtz, S; Zipperer, A | 1 |
| Ahmed, N; Ali, S; Farooq, S; Hussain, M; Khan, MA; Khan, S; Shamim, S | 1 |
| Bitschar, K; Dehmer, H; Focken, J; Götz, F; Grond, S; Kalbacher, H; Konnerth, M; Krismer, B; Kurschus, FC; Moos, S; Peschel, A; Sauer, B; Schilling, NA; Schittek, B | 1 |
| Berscheid, A; Brötz-Oesterhelt, H; Burian, M; Grond, S; Janek, D; Kalbacher, H; Konnerth, MC; Krismer, B; Laux, C; Marschal, M; Peschel, A; Schilling, NA; Schittek, B; Slavetinsky, C; Weidenmaier, C; Willmann, M; Zipperer, A | 1 |
| Chen, C; Han, S; Huang, R; Pan, B; Qu, D; Wei, P; Zheng, L; Zhu, M | 1 |
6 other study(ies) available for thiazolidines and Staphylococcal Infections
| Article | Year |
|---|---|
Antibacterial and antibiofilm activities of thiazolidine-2,4-dione and 4-thioxo-thiazolidin-2-one derivatives against multidrug-resistant Staphylococcus aureus clinical isolates.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Humans; Leukocytes, Mononuclear; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Thiazolidines | 2022 |
Secretion of and Self-Resistance to the Novel Fibupeptide Antimicrobial Lugdunin by Distinct ABC Transporters in Staphylococcus lugdunensis.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; ATP-Binding Cassette Transporters; Humans; Microbial Sensitivity Tests; Peptides, Cyclic; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus lugdunensis; Thiazolidines | 2020 |
Antimicrobial and synergistic activity of thiazoline derivatives in combination with conventional antibiotics against multidrug resistant Staphylococcus aureus isolated from abscess drainage samples.
Topics: Abscess; Anti-Bacterial Agents; Disk Diffusion Antimicrobial Tests; Drainage; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Ribotyping; Staphylococcal Infections; Staphylococcus aureus; Thiazoles; Thiazolidines | 2020 |
Lugdunin amplifies innate immune responses in the skin in synergy with host- and microbiota-derived factors.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cathelicidins; Cells, Cultured; Disease Models, Animal; Female; Humans; Immunity, Innate; Keratinocytes; Mice; Mice, Inbred C57BL; Mice, Knockout; Microbiota; Peptides; Peptides, Cyclic; Primary Cell Culture; Skin; Staphylococcal Infections; Staphylococcus aureus; Thiazolidines | 2019 |
Human commensals producing a novel antibiotic impair pathogen colonization.
Topics: Animals; Anti-Bacterial Agents; Carrier State; Disease Models, Animal; Drug Resistance, Microbial; Female; Humans; Male; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Microbiota; Nose; Peptides, Cyclic; Sigmodontinae; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus lugdunensis; Symbiosis; Thiazolidines | 2016 |
Thiazolidione derivatives as novel antibiofilm agents: design, synthesis, biological evaluation, and structure-activity relationships.
Topics: Anti-Bacterial Agents; Biofilms; Humans; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus epidermidis; Structure-Activity Relationship; Thiazolidines | 2011 |